No Detail Found!

In vitro susceptibility of chloramphenicol against methicillin-resistant Staphylococcus aureus.

Author(s)
Muhammad Fayyaz Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Irfan Ali Mirza Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Zaheer Ahmed Department of Microbiology, Yusra Medical College, Islamabad, Pakistan
Shahid Ahmad Abbasi Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Aamir Hussain Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Shamshad Ali Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi, Pakistan
Abstract
OBJECTIVE: To determine the in vitro susceptibility of chloramphenicol against methicillin-resistant Staphylococcus aureus. STUDY DESIGN: Cross-sectional study. PLACE AND DURATION OF STUDY: Department of Microbiology, Armed Forces Institute of Pathology, Rawalpindi, from January to June 2012. METHODOLOGY: One hundred and seventy four isolates of methicillin-resistant Staphylococcus aureus were included in this study using cefoxitin (30 mug) disc for detection. Minimum inhibitory concentration (MIC) of chloramphenicol against MRSA was determined by using E-strip (AB BIO DISK). The susceptibility was determined by swabbing the Mueller-Hinton agar (MHA) plates with the resultant saline suspension of MRSA and applying E-strip of chloramphenicol from AB Biodisk Sweden and determining the MIC of chloramphenicol (in mug/ml). Clinical and Laboratory Standards Institute (CLSI) recommendations of /=32 mug/ml as resistant were followed in interpreting the results. RESULTS: Out of the 174 MRSA isolates, 132 (75.86%) isolates were susceptible to chloramphenicol with MICs of /=32 mug/ml while 4 (2.30%) were in intermediate range with MIC of 16mug/ml. CONCLUSION: Chloramphenicol has shown good in vitro activity against MRSA and is likely to have a key role in the treatment of MRSA infections providing us a good alternative to newer expensive antimicrobials in resource limited countries.
Publication Details
Page(s) 637-640
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 23, Issue: 9, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

66

Views